DrugRepV_0014 | Anthocyanidin | Plant extract | NA | Zika virus | GZ01, a recent Asian lineage | NA | Plaque assay | No significant effect (20 %) | NA | 29033372 |
DrugRepV_1634 | Veratridine | Plant extract | NA | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | NA | 24991006 |
DrugRepV_1704 | Baicalein | Plant extract | Influenza | Zika virus | MR766 | NA | Cell viability assay | No significant effect (0 %) | Phase II | 27571349 |
DrugRepV_1775 | Baicalein | Plant extract | Influenza | Zika virus | MR766 | NA | Cell viability assay | No significant effect (0 %) | Phase II | 27571349 |
DrugRepV_1846 | Baicalein | Plant extract | Influenza | Zika virus | MR766 | NA | Cell viability assay | No significant effect | Phase II | 27571349 |
DrugRepV_2565 | Ginkgolide A | Plant extract | Inflammatory disorder | immunological disorder | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | Increase (-1.1811648 %) | Nutraceutical | 27742486 |
DrugRepV_2699 | Genipin | Plant extract | NA | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | Increase (-2.9384281 %) | NA | 27742486 |
DrugRepV_2978 | Chrysin | Plant extract | NA | Chikungunya virus | CHIKV replicon | NA | EGFP assay | Decrease (50 %) | Experimental | 22205980 |
DrugRepV_2987 | Chrysin | Plant extract | NA | Chikungunya virus | CHIKV replicon | NA | Rluc assay | Decrease (50 %) | Experimental | 22205980 |
DrugRepV_3021 | Bisdemethoxycurcumin | Plant extract | NA | Zika virus | HD78788 | NA | Plaque assay | Decrease | Early Phase I | 28343845 |
DrugRepV_3025 | Bisdemethoxycurcumin | Plant extract | NA | Chikungunya virus | La Reunion strain, 06-049 AM258994 | NA | Plaque assay | Decrease | Early Phase I | 28343845 |
DrugRepV_3029 | Bisdemethoxycurcumin | Plant extract | NA | Zika virus | HD78788 | NA | Plaque assay | Decrease (50 %) | Early Phase I | 28343845 |
DrugRepV_3034 | Bisdemethoxycurcumin | Plant extract | NA | Chikungunya virus | La Reunion strain, 06-049 AM258994 | NA | Plaque assay | Decrease (50 %) | Early Phase I | 28343845 |
DrugRepV_3123 | Chelidonine | Plant extract | NA | Chikungunya virus | CHIKV-0708 | NA | Immunoflourescence assay | Decrease (93.22 %) | NA | 23275491 |
DrugRepV_3159 | Iota-carrageenan | Plant extract | Common Cold | Chikungunya virus | Ross C347 | NA | Cytopathic effect (CPE) assay | Decrease (50 %) | Investigational | 14670584 |
DrugRepV_4298 | Baicalein | Plant extract | Influenza | Chikungunya virus | NA | NA | NA | Decrease (50 %) | Phase II | 27460167 |
DrugRepV_6167 | Baicalin | Plant extract | Influenza | Dengue virus | NA | | Focus forming reduction assay | Decrease | Phase II | 24965553 |
DrugRepV_6220 | Baicalein | Plant extract | Influenza | Dengue virus | New Guinea C | | Focus forming reduction assay | Decrease (50 %) | Phase II | 23140177 |
DrugRepV_7344 | Baicalein | Plant extract | Influenza | Japanese encephalitis virus | HE861351 | | Focus forming reduction assay | Decrease (50 %) | Phase II | 23222683 |
DrugRepV_7346 | Baicalein | Plant extract | Influenza | Japanese encephalitis virus | HE861351 | | Real-time PCR | Decrease (68.46 ± 1.19 %) | Phase II | 23222683 |
DrugRepV_7987 | Baicalein | Plant extract | Influenza | Enterovirus | 41 | | Plaque assay | Decrease (50 %) | Phase II | 32293397 |